A recent report showed that miRNA-34a inhibition promoted cancer cell proliferation, accelerated glucose uptake and upregulated GLUT1 expression in two triple-negative breast cancer cell lines used, but interestingly, was devoid of effect in the normal human breast epithelial cell line (Table 1) [103]. Here, SLC2A1 is linked to triple-negative breast carcinoma.